Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hasenclever

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Biometrical Journal. Biometrische Zeitschrift|January 24, 2007
Multiple targeted therapies: is there a place for Vach type-3 or type-4 design trialsDirk Hasenclever
The International Journal of Biostatistics|October 5, 2011
Comparison of estimators for measures of linkage disequilibriumMarkus Scholz, Dirk Hasenclever
Berliner Und Munchener Tierarztliche Wochenschrift|December 2, 2005
[Cost-utility analysis of surgical obstetrics in cattle with torsio uteri intra partum]Axel Schönfelder, Dirk Hasenclever
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2014
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and MarthanDirk Hasenclever, Lars Kurch, Regine Kluge
Bulletin of Mathematical Biology|December 17, 2013
Modelling lymphoma therapy and outcomeKatja Roesch, Dirk Hasenclever, Markus Scholz
The New England Journal of Medicine|February 4, 2016
Remote Ischemic Preconditioning and Cardiac SurgeryPatrick Meybohm, Dirk Hasenclever, Kai Zacharowski
Leukemia & Lymphoma|December 16, 2015
Modeling combined chemo- and immunotherapy of high-grade non-Hodgkin lymphomaKatja Rösch, Markus Scholz, Dirk Hasenclever
Transfusion|August 21, 2024
The effectiveness of telephone surveys on the return of first-time donors: A randomized controlled trialVanessa C Marsano, Dirk Hasenclever, Reinhard Henschler
Antiviral Therapy|May 29, 2008
Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidenceJohannes Wiegand, Dirk Hasenclever, Hans L Tillmann
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET"Regine Kluge, Sally Barrington, Lars Kurch, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Biometrical Journal. Biometrische Zeitschrift|January 24, 2007
Multiple targeted therapies: is there a place for Vach type-3 or type-4 design trialsDirk Hasenclever
The International Journal of Biostatistics|October 5, 2011
Comparison of estimators for measures of linkage disequilibriumMarkus Scholz, Dirk Hasenclever
Berliner Und Munchener Tierarztliche Wochenschrift|December 2, 2005
[Cost-utility analysis of surgical obstetrics in cattle with torsio uteri intra partum]Axel Schönfelder, Dirk Hasenclever
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2014
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and MarthanDirk Hasenclever, Lars Kurch, Regine Kluge
Bulletin of Mathematical Biology|December 17, 2013
Modelling lymphoma therapy and outcomeKatja Roesch, Dirk Hasenclever, Markus Scholz
The New England Journal of Medicine|February 4, 2016
Remote Ischemic Preconditioning and Cardiac SurgeryPatrick Meybohm, Dirk Hasenclever, Kai Zacharowski
Leukemia & Lymphoma|December 16, 2015
Modeling combined chemo- and immunotherapy of high-grade non-Hodgkin lymphomaKatja Rösch, Markus Scholz, Dirk Hasenclever
Transfusion|August 21, 2024
The effectiveness of telephone surveys on the return of first-time donors: A randomized controlled trialVanessa C Marsano, Dirk Hasenclever, Reinhard Henschler
Antiviral Therapy|May 29, 2008
Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidenceJohannes Wiegand, Dirk Hasenclever, Hans L Tillmann
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET"Regine Kluge, Sally Barrington, Lars Kurch, et al.
Pageof 10